Скачать с ютуб Hematology Horizons: Community AML в хорошем качестве

Hematology Horizons: Community AML

Join Elissa Baldwin from the LLS Patient Education team as she visits with Dr. Luke Fletcher from Willamette Valley Cancer Institute in Eugene, OR. In this episode, Dr. Fletcher discusses how acute myeloid leukemia (AML) is treated in a community oncology clinic, highlighting the importance of local care for patients who may not live close to major cancer centers. He also shares insights into the latest treatment advances, including menin inhibitors and novel combination therapies that are shaping the future of AML care. For patients with other blood cancers living in rural or underserved areas, tune in at timestamps 10:18 and 18:11 to learn more about oncology care in the community setting and how local clinics coordinate with larger cancer centers to support comprehensive treatment. Want to see more? Visit https://www.LLS.org/Vlog This episode supported by Abbvie Inc. (00:00) Introduction (00:28) What is AML? (02:21) What are current treatments for AML? (10:18) Oncology care in the community setting (11:37) Clinical trials in the community setting (12:23) What treatment in the community oncology setting looks like (14:31) Local treatment for AML (16:36) Stem cell transplant and supportive care (18:11) Challenges for community oncology patients (19:11) Resources and support services for patients (21:25) Hope for AML patients in rural communities (22:02) Finding a doctor and getting a second opinion (24:07) Emerging therapies for AML